Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07325682 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diagnostic Evaluation of Viral Persistence in Cervical Cancer

Study acronym: PETCVOCC
StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Jun 30, 2026 → Jun 30, 2030
See other at-risk trials from Oncology Center,Ministry Of Heath,Uzbekistan

Record History

  1. Primary completion pushed from Jun 30, 2026 to Jun 30, 2030 Eligibility criteria expanded, about 11 words · Study site revised Show 2 more changesShow less
    • Eligibility criteria expanded, about 11 words
    • Study site revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the diagnostic value of an electroacupuncture-based method for detecting viral persistence (human papillomavirus and SARS-CoV-2) in patients with cervical cancer. The study investigates whether persistent viral signatures can be identified through measurable electrodiagnostic responses at acupuncture points associated with organ systems affected by chronic viral infection. The goal is to assess the feasibility, reproducibility, and potential clinical relevance of this diagnostic approach in oncology patients.
Trial Details
NCT Number NCT07325682
Lead Sponsor Oncology Center,Ministry Of Heath,Uzbekistan
Conditions Cervical Cancer
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov